Pregled bibliografske jedinice broj: 1258606
Validation of the dermatology‐specific proxy instrument the Infants and Toddlers Dermatology Quality of Life
Validation of the dermatology‐specific proxy instrument the Infants and Toddlers Dermatology Quality of Life // JEADV. Journal of the European academy of dermatology and venereology, 33 (2019), 7; 1405-1411 doi:10.1111/jdv.15496 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1258606 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Validation of the dermatology‐specific proxy instrument the Infants and Toddlers Dermatology Quality of Life
(Validation of the dermatology‐specific proxy instrument the Infants and Toddlers Dermatology Quality of
Life)
Autori
Chernyshov, P.V. ; Sampogna, F. ; Pustišek, N. ; Marinovic, B. ; Manolache, L. ; Suru, A. ; Salavastru, C.M. ; Tiplica, G.S. ; Stoleriu, G. ; Kakourou, T. ; Alexopoulos, A. ; Nasi, L. ; Szepietowski, J.C. ; Trzeciak, M. ; Nowicki, R.J. ; Chubar, O.V. ; Chernyshov, A.V. ; Pochynok, T.V.
Izvornik
JEADV. Journal of the European academy of dermatology and venereology (0926-9959) 33
(2019), 7;
1405-1411
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
dermatology-specific ; proxy instrument ; infants ; toddlers
Sažetak
Background: The first dermatology-specific proxy health-related quality of life (HRQoL) instrument for children 0-4 years old with skin diseases, the Infants and Toddlers Dermatology Quality of Life (InToDermQoL), was recently developed. In order to avoid the problem of cross-cultural inequivalence focus groups work and pilot tests were organized simultaneously in all national centres of the project. The InToDermQoL showed good comprehensibility, clarity and acceptance. Objective: To validate the InToDermQoL questionnaire during international field tests. Methods: Internal consistency, test-retest reliability, convergent and discriminant validity of the InToDermQoL questionnaire were checked during international field tests. Results: Parents of 473 children with skin diseases filled in the national language versions of the InToDermQoL questionnaire. All three age-specific versions of the InToDermQoL questionnaire with 10, 12 and 15 items, respectively, showed high internal consistency (Cronbach's α 0.90-0.93), good test- retest reliability (correlation coefficients > 0.9), significant correlations with the most widely used atopic dermatitis-specific proxy instrument, the Infants Dermatitis Quality of Life Index (correlation coefficients 0.68-0.79). The InToDermQoL versions for children <3 years old well correlated with the atopic dermatis severity measure Scoring of Atopic Dermatitis (correlation coefficients 0.66 and 0.86 for 10 and 12 items versions, respectively). The InToDermQoL questionnaire discriminated well among different diagnoses and disease severity levels. Conclusion: Our field tests confirmed internal consistency, test-retest reliability, convergent and discriminant validity of the InToDermQoL questionnaire. Development and validation of the InToDermQoL questionnaire make it possible to assess dermatology-specific aspects of HRQoL in youngest children with skin diseases. There are many reasons to assess HRQoL in dermatologic clinical practice, and we hope that our new instrument will be used internationally in paediatric dermatology for research and practical needs.
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
Klinika za dječje bolesti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE